Acutaas Chemicals Ltd Hits All-Time High, Marking a Milestone in Market Performance

Record-Breaking Price Movement and Market Outperformance

On 26 Feb 2026, Acutaas Chemicals Ltd achieved a fresh 52-week high, closing at Rs.2187.95. This milestone was accompanied by a daily gain of 0.88%, significantly outperforming the Sensex, which recorded a modest 0.06% increase on the same day. The stock has demonstrated remarkable momentum, registering gains for five consecutive trading sessions and delivering a cumulative return of 3.43% during this period.

Volatility was notably elevated, with an intraday weighted average price volatility of 36.36%, indicating active trading and investor engagement. Furthermore, Acutaas Chemicals is trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a strong upward trend across multiple time horizons.

Comparative performance metrics further highlight the stock’s strength. Over the past week, it outpaced the Sensex by 4.12 percentage points, delivering a 3.91% return versus the benchmark’s decline of 0.21%. The one-month return stands at an impressive 32.26%, dwarfing the Sensex’s 0.96% gain. Over three months, the stock appreciated by 21.84%, while the Sensex fell by 3.84%. The one-year performance is particularly striking, with Acutaas Chemicals surging 90.98% compared to the Sensex’s 10.35% rise. Year-to-date, the stock has gained 28.25%, contrasting with the Sensex’s 3.40% decline. Over a three-year horizon, the stock’s return of 377.92% vastly outstrips the Sensex’s 38.44%.

Financial Strength and Operational Excellence Driving Growth

Acutaas Chemicals Ltd’s ascent to its all-time high is underpinned by a series of robust financial indicators. The company maintains a low average Debt to Equity ratio of zero, reflecting a debt-free capital structure that enhances financial stability and flexibility.

Net sales have expanded at a compounded annual growth rate of 26.84%, while operating profit has grown even more rapidly at 38.56% annually. The latest quarterly net sales figure stood at Rs.393.18 crores, representing a 43.4% increase compared to the average of the previous four quarters. This growth trajectory is complemented by a net profit increase of 47.82%, with the company declaring outstanding results in December 2025.

Operational efficiency is evident in key metrics such as the Return on Capital Employed (ROCE), which reached a high of 21.30% in the half-year period, and the Inventory Turnover Ratio, which peaked at 5.74 times. These figures indicate effective utilisation of capital and inventory management, contributing to the company’s profitability and cash flow generation.

Institutional investors hold a significant 38.38% stake in the company, signalling confidence from entities with substantial analytical resources and long-term investment horizons.

Acutaas Chemicals Ltd is recognised among the top 1% of companies rated by MarketsMojo across a universe of over 4,000 stocks. It holds a rank of 7 among Small Cap companies and 19 across the entire market, reflecting its strong fundamentals and market standing. The company’s Mojo Score stands at 82.0, with a recent upgrade from a Buy to a Strong Buy grade on 6 Oct 2025, underscoring improved quality and growth prospects.

Valuation and Market Position

While the company’s financial performance is impressive, valuation metrics indicate a premium positioning. The Price to Book Value ratio is 12.5, which is considered very expensive relative to peers. The Return on Equity (ROE) is 15.8%, reflecting solid profitability but also contributing to the elevated valuation.

The Price/Earnings to Growth (PEG) ratio stands at 0.5, suggesting that the stock’s price growth is supported by earnings growth, albeit at a premium level. Over the past year, profits have risen by 136%, outpacing the stock’s 90.98% return, which indicates strong earnings momentum relative to price appreciation.

Long-Term Market Leadership and Sectoral Context

Acutaas Chemicals Ltd operates within the Pharmaceuticals & Biotechnology sector, a space characterised by innovation and growth potential. The company’s market capitalisation grade is 3, indicating a mid-sized market presence with room for expansion.

Its sustained outperformance relative to the BSE500 index over multiple time frames – including one year, three months, and three years – highlights its ability to generate superior returns consistently. The stock’s year-to-date gain of 28.25% contrasts with the Sensex’s decline of 3.40%, emphasising its resilience amid broader market fluctuations.

Trading above all major moving averages and maintaining a strong Mojo Grade of Strong Buy, Acutaas Chemicals Ltd’s current valuation and performance metrics reflect a company that has successfully navigated growth phases and market cycles to reach this historic price level.

Summary of Key Metrics

To encapsulate, the stock’s all-time high is supported by:

• New 52-week high of Rs.2187.95
• 90.98% one-year return versus 10.35% Sensex gain
• Consistent quarterly positive results over six consecutive quarters
• Strong financial ratios including ROCE at 21.30% and Inventory Turnover at 5.74 times
• Debt-free capital structure with zero average Debt to Equity ratio
• High institutional ownership at 38.38%
• Mojo Score of 82.0 and upgraded Mojo Grade to Strong Buy

These factors collectively illustrate a company that has delivered sustained growth and market leadership, culminating in the significant milestone of an all-time high stock price.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →